“…Some studies suggest that it represent 0.04% to 1.2% of spinal tumours, 2% to 3% of epidural spinal tumors (1,3,5,6,8) and 16 % to 35 % of spinal lipomas (5,8). It has a female predominance (1,2,3,4,5,7,8) with a sex ratio of 3/2 (8), with an average age between 40 and 60 years(2,3,4,7) and mostly located in thoracic spine (1,2,3,4,5,6,7,8) in 78 % of cases (8), mostly between Th2 and Th5 (6), other location are less common, it occurs in 10 % in the lumbar spine and in 1 % in the cervical spine (8).SAL can be infiltrating or non-infiltrating, In the majority of cases it is non infiltrating encapsulated and limited in the epidural space (3,7,8).The clinical presentation include back pain and signs of spinal cord compression (1,2,3,4,5,6,7,8), although the symptoms evolves slowly some cases of acute paraplegia were described (4).MRI is the imaging of choice for SAL diagnosis (1,2,3,4,5,6,7,8) ,commonly the tumour has a fusiform shape located in the posterior epidural space (2,4,5), the signal of the lesion is the reflect of its two components: lipomatose and angiomatose, so SAL is usually hyperintense in T1 and T2 weighted images with loss of the signal in fat suppression sequences which could be regained after injection of gadolinium (1,2,3,6,8).Surgery is the reasonable treatment modality (1,2,3,4,6,<...>…”